Zweiter Anfall: Anamnese und Screening-Formen von Roy Strowd, MD

video locked

Über den Vortrag

Der Vortrag „Zweiter Anfall: Anamnese und Screening-Formen“ von Roy Strowd, MD ist Bestandteil des Kurses „Anfälle und Epilepsie“.


Quiz zum Vortrag

  1. After a focal-onset seizure, a patient has a 60% risk of recurrence.
  2. A generalized seizure has a greater risk of recurrence than a focal-onset seizure.
  3. Seizures occurring during sleep have a lower risk of recurrence than those occurring while awake.
  4. After experiencing a nocturnal seizure, a subsequent seizure is most likely to occur during the day.
  5. Patients experiencing bizarre nocturnal behaviors should be reassured that recurrence is unlikely.
  1. EEG
  2. ECG
  3. Blood work
  4. Toxicology screening
  5. Head CT
  1. An EEG can determine specific epileptiform patterns and non-specific paroxysmal depolarization shifts.
  2. Epileptiform discharges do not occur in healthy adults or children.
  3. Having a neurological disease does not change the likelihood of epileptiform discharges.
  4. Compared with a single EEG, a serial EEG decreases the diagnostic sensitivity of the study.
  5. The time elapsed between a seizure and the initial EEG does not impact sensitivity.
  1. All patients with a first-time seizure should undergo a CT or MRI.
  2. MRI and CT have equal sensitivity in determining the epileptic focus.
  3. After a first-time seizure, an MRI has almost a 75% success rate in determining the epileptic focus.
  4. If the CT is negative, a seizure focal point should be ruled out regardless of suspicion.
  5. Neuroimaging is used to guide treatment options, but it cannot predict recurrence risk.
  1. Overall, a patient with a normal MRI has a 40% chance of seizure recurrence.
  2. An abnormal EEG after the first seizure suggests a 90% chance of recurrence.
  3. A negative EEG after a seizure suggests a recurrence risk of < 5%.
  4. An epileptogenic lesion on MRI after the first seizure indicates an 80% risk of recurrence.
  5. EEG does not predict recurrence risk.

Dozent des Vortrages Zweiter Anfall: Anamnese und Screening-Formen

 Roy Strowd, MD

Roy Strowd, MD

Dr. Roy Strowd is the Assistant Dean of Undergraduate Medical Education at the Wake Forest Baptist Medical Center, in North Carolina, USA.
He obtained his MD from Wake Forest School of Medicine in 2009, and his MEd from Johns Hopkins University in 2021. Currently, he co-directs the Neurofibromatosis and Tuberous Sclerosis Clinics at Wake Forest Baptist Medical Center, and is a researcher for the Adult Brain Tumor Consortium (ABTC) and Alliance for Clinical Trials in Neuro-Oncology.
Due to his achievements, he earned the M. Brownell Anderson Award from the Association of American Medical Colleges.
Within Lecturio, Dr. Strowd teaches courses on Clinical Neurology.


Kundenrezensionen

(1)
5,0 von 5 Sternen
5 Sterne
5
4 Sterne
0
3 Sterne
0
2 Sterne
0
1  Stern
0